| |
BioPlan Publications
 |
|
A Quick Guide to Healthcare and Biotechnology in the Middle East
"For the rest of us..."
BioPlan Associates, Inc., April 2009
Overview
Until recently, the Middle East has accounted for a fraction of global pharmaceutical sales, but BioPlans newly released A Quick Guide to Healthcare and Biotechnology in the Middle East shows that dramatic change is underway. The Middle East has been low on the agenda of the pharmaceutical industry, due to reliance on strong growth in the US, European and Japanese markets, but the slowdown and cost containment pressures in these markets have persuaded the pharmaceutical industry to cast its eyes further afield.
The total Middle East regional value is around US$10.6 billion and growing rapidly. Multinational pharmaceutical companies can no longer ignore the regions huge potential. Due to varying socio-economic conditions and political developments across the Middle East, it is entirely conceivable for companies to find opportunities for products in almost every therapeutic area.
The high demand for premium products has led to multinational companies having dominated the Middle East. Pharmaceutical companies still need to be aware of the regions dynamics. This is still very much an emerging market and you have to do your homework.
ISBN: 978-1-934106-15-0
Order Now
|
|
 |
|
6th Annual Report on Biopharmaceutical Manufacturing Capacity and Production
BioPlan Associates, Inc., April 2009
This comprehensive look at the state of worldwide biopharmaceutical manufacturing provides the only on-going assessment of manufacturing capacity and production in this $80 billion global industry. You will find current, quantitative information from 446 worldwide biopharmaceutical developers and contract manufacturers, and over 140 suppliers to the industry. Covers year 2008.
ISBN: 978-1-934106-16-7
Download Brochure 
Download Table of Contents
Order Now
|
|
 |
|
A Quick Guide to BioFuels: When the Oil Runs Out
BioPlan Associates, Inc., January 2010
Overview
Biofuels can power Indy cars, automobiles, and airplanes as well as trucks and buses. Yet they are hotly debated:
- Do biofuels help slow global warming or contribute to atmospheric CO2?
- Will biofuels snatch food from the mouths of the worlds poor?
- Are rainforests being decimated as biofuels reduce global biodiversity?
- Can we even afford biofuels?
One answer is easy: plants (biomass) are a potential alternative to the worlds unhealthy addiction to fossil fuels, and especially to oil. The timeline of oil depletion be dangerously short. Mankind needs solutions for when the oil runs out as it eventually will. This book's ten chapters explain how to best use that important know how.
This is a concise and uncomplicated history, status and outlook for the biofuels agenda that is applicable for layman as well as the industry insider. The information presented here on this imperative topic is beneficial to everyone, whether youll be financing biofuels, producing it or just pumping it into your fuel tank.
Author: Dr. John Mousdale
Published by BioPlan Associates, Inc. January 2010
ISBN: 978-1-934106-17-4
Download Brochure
Download Table of Contents and Contributors
Order Now
|
|
 |
|
A Quick Guide to Clinical Trials for People Who May Not Know It All
BioPlan Associates, Inc., April 2008
Why should I read this book?
Appropriately designed and executed clinical trials are at the heart of the successful development of new medicines for patients. This book provides a unique view of the clinical trials process. You will be able to see exactly how any given discipline fits in and plays its part in delivering the overall clinical trial program. The successful design, execution and delivery of an effective clinical trial program relies on excellent cooperation, understanding and respect within an often widely dispersed multi-disciplinary team. The chapters are jargon-lite but detailed enough to provide the framework onto which you, the reader, can attach that jargon when you are good and ready. Each chapter also stands alone as a quick dip foundation or refresher. Everyone involved in clinical trials finds it demanding to keep up-to-date with current developments in the field. We believe you will come away with a really good basic grasp of the excitement of the clinical trials process, its drivers, checks and balances, and how you may even be able to contribute in a wide variety of ways.
Edited by Drs. Madhu Davies and Faiz Kermani.
Published by BioPlan Associates, Inc. April 2008
ISBN: 978-1-934106-08-2
Download Table of Contents and Contributors
Order Now
|
|
 |
|
The essential resource for technological, manufacturing, marketing, regulatory, patent and competitive information.
BioPlan Associates, Inc.,
- Every biopharmaceutical approved in the US and EU, and those with filings expected through 2009.
- Over 580 in-depth product monographs: Encyclopedic, analytical, detailed descriptions, manufacturing, historical, competitive, technological and regulatory intelligence and alliances, patents, partnerships, marketing, sales agreements, much more!
- Find composition, activity, nomenclature, companies involved and relationships, manufacturing processes, technology transfer, regulatory history/status, approved indications, prices, market size/share, controversial aspects, etc.
- Superior search capabilities! Easily searched by 12 different parameters!
- Full-featured Web databases many specific search fields; links between products and companies.
- Unique and hard-to-find information.
- Regularly updated, too!
- Indexes 33,000+ index entries makes searching easy! Search by product, active agent, nomenclature, class, market size, expression system/host cell/source, regulatory status and approval date; company, role, country, state, marketing territory.
- Get the scientific, technological, regulatory, commercial information and competitive intelligence you need to fully understand biopharmaceutical products and the industry.
- More than a directory - Besides detailed descriptions and indexing, includes competitive, technological and regulatory intelligence; much unique and hard-to-find information.
- Free Product and Company Web databases to locate monographs in the book
- Full text Web database subscriptions available
Author: Ronald A. Rader
Download Flier
SINGLE USER LICENSE: Order Now
GLOBAL ENTERPRISE LICENSE: Order Now
|
|
 |
|
Biopharmaceutical Expression Systems and Genetic Engineering Technologies
BioPlan Associates, Inc., November 2008
New expression systems and recent improvements available for current systems have the potential to revolutionize the biopharmaceutical industry!Lower costs and efficiencies of newer expression systems are driving these changes.
This book provides you with the information you need to make the shift to increased productivity. As reflected by currently marketed products, since the advent of genetic engineering in the 1970s, there has been little basic change in the technologies used for commercial-scale manufacture of biopharmaceutical products.
Nearly all current products are manufactured using much the same old, familiar technologies primarily using Esherichia coli (E. coli bacterium), Chinese hamster ovary (CHO) cells and the yeast Saccharomyces cerevisiae (S. cerevisiae) as hosts technologies invented in the 1970s and commercialized in the 1980s.
By Ronald A. Rader
Published by the BioPlan Associates, Inc. November 2008
ISBN: 978-1-934106-08-2
Order Now
Also available to download as a Global Digital License
|
|
 |
|
Directory of Top 60 Biopharmaceutical Manufacturers in India
BioPlan Associates, Inc., September 2008
The first edition of the BioPlan India Biopharmaceutical Index, includes the Top 60 Biopharmaceutical Companies in India, with detailed profiles of their business focus, products, revenues, R&D and business strategies, international objectives, partnering strategies, and marketing activities. In addition, subscribers will receive on-going updates to activities and trends in India as the country's biopharmaceutical industry expands.
- Plus, you'll get easy access to dozens more biopharma companies in India
- Our India Biopharmaceutical Index provides you quarterly trending of activities and changes occurring in the region. Be sure to keep up-to-date on Whos Who in India, and understand this dynamic, rapidly changing market
Published by BioPlan Associates, Inc. April 2008
ISBN: 978-1-934106-12-9
Download Table of Contents
Download PDF Brochure
Order Now
|
|
 |
|
Directory of Top 60 Biopharmaceutical Manufacturers in China
BioPlan Associates, Inc., February 2008
The first edition of the BioPlan China Biopharmaceutical Index includes the Top 60 Biopharmaceutical Companies in China, with detailed profiles of their business focus, products, revenues, R&D and business strategies, international objectives, partnering strategies, and marketing activities. In addition, subscribers will receive on-going updates to activities and trends in China as the countrys biopharmaceutical industry expands. Our China Biopharmaceutical Index and our Top 60 Directory provide you information on trending of activities and changes occurring in the region. Be sure to keep up-to-date on Whos Who in China. This report will help ensure youre current, and have a solid understanding of this dynamic, rapidly changing market.
Author: Yibing (Eliza) Zhou
Published: BioPlan Associates, Inc., February 2008
ISBN: 978-1-934106-11-2
Order Now
|
|
 |
|
Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd Edition
BioPlan Associates, Inc., November 2007
A Comprehensive Study of the Science, Technology and Business of Biopharmaceutical Manufacturing.
Published by the ASM Press [American Society for Microbiology Press] and BioPlan Associates, Inc., November 2007
ISBN: 978-1-934106-11-2
Download Table of Contents
Order Now
|
|
 |
|
Advances in Biopharmaceutical Technology in India
BioPlan Associates, Inc., January 2008
A Society for Industrial Microbiology and BioPlan Associates co-publication
BioPlan Associates in India can provide you the most up-to-date news and perspective on events and trends in this rapidly-changing biopharmaceutical industry. Whether you require basic information, or extensive support in partnering with the right companies in India, BioPlan will work with you to meet your needs.
Published: BioPlan Associates, Inc. and Society for Industrial Microbiology. January 2008
ISBN: 978-1-934106-07-5
Download Table of Contents
Download Brochure
Order Now
|
|
 |
|
Biopharmaceuticals in the US and European Markets, 6th Edition
BioPlan Associates, Inc., September 2007
The only reference book (and databases) concerning biopharmaceutical products!
- Encyclopedic monographs concentrate on products' biotechnology and commercial aspects
- Includes all biopharmaceuticals - recombinant and other proteins, monoclonal antibodies, vaccines, enzymes, blood products, radioimmune conjugates, cultured cells and tissues
- More than a directory - Besides detailed descriptions and indexing, includes competitive, technological and regulatory intelligence; much unique and hard-to-find information.
- Free Product and Company Web databases to locate monographs in the book
- Full text Web database subscriptions available
Author: Ronald A. Rader
Publisher: BioPlan Associates, Inc, September 2007
ISBN: 978-1-934106-04-4 (2 Vol Set)
Download Flier (6th Edition)
Download Table of Contents (6th Edition)
Order Now
|
|
 |
|
Advances in Biopharmaceutical Technology in China
BioPlan Associates, Inc.,
A Society for Industrial Microbiology and BioPlan Associates co-publication
Every organization has a China strategy, though for many of us it is simply "ignore it." A great opportunity exists in working with China and implementing an effective company strategy. However, winning in Asia in the new millennium will require fundamental changes in partnerships between western and Asian companies. Every company faces the question "What should our China strategy be?" But to neglect China is to forego opportunities to gain efficiency in most of the things we are trying to do. China provides opportunities that allow us to do different things and not just do things differently.
This volume provides an overview of the biopharmaceutical industry, and the state of technology. It will help the reader understand general business practice in China, analyze business opportunities and in identifying potential partners for working in China. It provides a ready reference for all aspects of the world of biopharmaceuticals in China, including general understanding, detailed technical and business descriptions, and detailed information on all types of organizations involved in biopharmaceuticals in China, whether they be companies (state owned or privately owned), universities, or government institutions.
Download Brochure
Order Now
|
|
 |
|
A Survey of Education and Training in Life Sciences Commercialization
BioPlan Associates, Inc., July 2003
Education and training in the Life Sciences, and in Biotechnology has been indicated through a number of anecdotal assessments, and quantitative studies to be a major factor in the effective commercialization of products. Whether in production, R&D or on the business side, workforce issues continue to present challenges and competitive opportunities for life sciences companies. This study focuses on the impact that education and training is having on the commercialization of life sciences products and services. We conducted a benchmarking study to evaluate the impact of levels of education and training in biotechnology. We surveyed 100 senior managers involved in the commercialization of technology, products and services at biotechnology companies in the United States and Canada. Respondents included senior managers, VPfs of marketing, sales, product managers, and others. The ability to meet the demand for a skilled workforce, whether through in-house training or out-sourced education, carries long-term strategic implications for companies and requires accurate needs assessment, and lead-time. This White Paper provides a quantitative assessment of the industryfs current situation, and offers a view into potential industry bottlenecks that may develop based on potential shortfalls in education and training.
Order Now
|
|
 |
|
Biopharmaceutical Manufacturing Capacity Survey
BioPlan Associates, Inc., November 2003
Download Cover and Table of Contents
E-mail Helix Research Center to request purchase information
|
|
 |
|
Technimanagement: The Human Side of the Organization
BioPlan Associates, Inc., August 1997
E-mail Helix Research Center to request purchase information
|
|
To order any of the above books, please mail to admin@helixresearchcenterworld.com or contact here
Click here to go back to the main publications page: Back
|
